CPT code 15277 denotes the application of a skin substitute (allograft or xenograft) for coverage of wounds involving anatomically sensitive or multiple sites when the treated area is ≥100 cm2 in patients 10 and older, or 1% of body area in children under 10. This code captures complex wound management using biological dressings on areas such as the face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and multiple digits. Nationally, the code matters for consistent coding of advanced wound care and for tracking the use of skin substitutes across surgical and outpatient settings.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarking and policy-relevant context for billing and coverage of skin substitute applications, including typical sites of service and clinical scenarios that align with code descriptors. The publication outlines clinical context for use, common modifiers in payer practice patterns, and where to find related coding guidance. Data not available in the input are noted where applicable. This summary equips clinicians, billing specialists, and policy analysts with a clear understanding of when CPT code 15277 applies and what national stakeholders typically consider when assessing claims for large or complex wound skin substitute applications.